{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:47:50Z","timestamp":1792298870377,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11046-018-0299-9","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T03:50:50Z","timestamp":1538711450000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan"],"prefix":"10.1007","volume":"184","author":[{"given":"Shigehiro","family":"Hagiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kamewada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayasu","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Shinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Makimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"299_CR1","doi-asserted-by":"crossref","unstructured":"Satish HS, Viswanatha B, Manjuladevi M. A clinical study of otomycosis. IOSR J Dent Med Sci. 2013;5(2):2279\u20130861.","DOI":"10.9790\/0853-0525762"},{"key":"299_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1439-0507.2011.02132.x","volume":"55","author":"X Jia","year":"2012","unstructured":"Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012;55:404\u20139.","journal-title":"Mycoses"},{"key":"299_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11046-011-9427-5","volume":"172","author":"L Garcia-Agudo","year":"2011","unstructured":"Garcia-Agudo L, Aznar-Marin L, Galan-Sanchez F, Garcia-Martos P, Marin-Casanova P, Rodrigues-Iglesias M. Otomycosis due to filamentous fungi. Mycopathologia. 2011;172:307\u201310.","journal-title":"Mycopathologia"},{"key":"299_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1439-0507.2007.01441.x","volume":"51","author":"J Fasunla","year":"2007","unstructured":"Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2007;51:67\u201370.","journal-title":"Mycoses"},{"key":"299_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1439-0507.2007.01409.x","volume":"50","author":"DA Kaya","year":"2007","unstructured":"Kaya DA, Kiaz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007;50:447\u201350.","journal-title":"Mycoses"},{"key":"299_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3314\/jjmm.44.277","volume":"44","author":"T Egami","year":"2003","unstructured":"Egami T, Noguchi M, Ueda S. Mycosis in the ear, nose and throat. Jpn J Med Mycol. 2003;44:277\u201383 (in Japanese with English abstract).","journal-title":"Jpn J Med Mycol"},{"key":"299_CR7","first-page":"1","volume":"19","author":"S Gheith","year":"2014","unstructured":"Gheith S, Saghrouni F, Bannour W, Youssef YB, Khelif A, Normand AC, Piarroux R, Said MB, Njah M, Ranque S. In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia. SpringerPlus. 2014;19:1\u20138.","journal-title":"SpringerPlus"},{"key":"299_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1439-0507.2011.02049.x","volume":"55","author":"M Hendrickx","year":"2011","unstructured":"Hendrickx M, Beguin H, Detandt M. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM\/IHEM collection. Mycoses. 2011;55:148\u201355.","journal-title":"Mycoses"},{"key":"299_CR9","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1128\/JCM.01070-09","volume":"47","author":"SA Balajee","year":"2009","unstructured":"Balajee SA, Kano R, Baddly JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47:3138\u201341.","journal-title":"J Clin Microbiol"},{"key":"299_CR10","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1128\/AAC.00585-09","volume":"53","author":"L Alcazar-Fuoli","year":"2009","unstructured":"Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rordriguez-Tudela JL. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother. 2009;53:4514\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"299_CR11","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1128\/AAC.00383-13","volume":"57","author":"A Alastruey-Lzquierdo","year":"2013","unstructured":"Alastruey-Lzquierdo A, Mellado E, Pelaez T, Peman J, Zapico S, Alvarez M, Rodriguez-Tudela J, Cuenca-Estrella M. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP study). Antimicrob Agents Chemother. 2013;57:3380\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"299_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/JCM.03233-14","volume":"53","author":"Y Li","year":"2015","unstructured":"Li Y, Wan Z, Liu W, Li R. Identification and susceptibility of Aspergillus section nigri in China: prevalence of species and paradoxical growth in response to echinocandins. J Clin Microbiol. 2015;53:702\u20135.","journal-title":"J Clin Microbiol"},{"key":"299_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/mmy\/myv118","volume":"54","author":"M Gautier","year":"2016","unstructured":"Gautier M, Normand AC, L\u2019Ollivier C, Cassagne C, Reynaud-Gaubert M, Dubus JD, Bregeon F, Hendrickx M, Gomez C, Ranque S, Piarroux R. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease. Med Mycol. 2016;54:459\u201370.","journal-title":"Med Mycol"},{"key":"299_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11046-012-9529-8","volume":"174","author":"G Szigeti","year":"2012","unstructured":"Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgy C, Varga J. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012;174:143\u20137.","journal-title":"Mycopathologia"},{"key":"299_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1439-0507.2011.02103.x","volume":"55","author":"G Szigeti","year":"2012","unstructured":"Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, Varga J. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012;55:333\u20138.","journal-title":"Mycoses"},{"issue":"4","key":"299_CR16","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1128\/AAC.00942-07","volume":"52","author":"L Alcazar-Fuoli","year":"2008","unstructured":"Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Aspergillus section Fumigati: antifungal Susceptibility Patterns and sequence-based identification. Antimicrob Agents Chemother. 2008;52(4):1244\u201351.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"299_CR17","first-page":"564","volume":"30","author":"K Anwar","year":"2014","unstructured":"Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30(3):564\u20137.","journal-title":"Pak J Med Sci"},{"key":"299_CR18","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1128\/AAC.02056-12","volume":"57","author":"WJJ Siu","year":"2013","unstructured":"Siu WJJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, Fothergill A. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother. 2013;57:1610\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"299_CR19","first-page":"1","volume":"20","author":"A Tupaki-Sreepurna","year":"2017","unstructured":"Tupaki-Sreepurna A, Jishnu BT, Thanneru V, Sharma S, Gopi A, Sundaram M, Kindo AJ. An assessment of in vitro antifungal activities of efinaconazole and itraconazole against common non-dermatophyte fungi causing onychomycosis. J Fungi. 2017;20:1\u20138.","journal-title":"J Fungi"},{"key":"299_CR20","unstructured":"De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of clinical fungi, 2nd edn. Washington: American Society for Microbiology; 2014. p. 442\u20133."},{"key":"299_CR21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/JCM.37.4.920-924.1999","volume":"37","author":"K Makimura","year":"1999","unstructured":"Makimura K, Tamura Y, Mochizuki T, Hasegawa A, Tajiri Y, Hanzawa R, Uchida K, Saito H, Yamaguchi H. Phylogenetic classification of dermatophyte strains based on DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Clin Microbiol. 1999;37:920\u20134.","journal-title":"J Clin Microbiol"},{"key":"299_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/1348-0421.12375","volume":"60","author":"K Satoh","year":"2016","unstructured":"Satoh K, Yamazaki T, Nakayama T, Umeda Y, Alshahni MM, Makimura M, Makimura K. Characterization of fungi isolated from the equipment used in the International Space Station or Space Shuttle. Microbiol Immunol. 2016;60:295\u2013302.","journal-title":"Microbiol Immunol"},{"key":"299_CR23","unstructured":"Clinical and Laboratory Standards Institute. M38-A2 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. 2nd edn; 2008. Vol. 28 No. 16."},{"key":"299_CR24","first-page":"486","volume":"63","author":"H Ishidaira","year":"2014","unstructured":"Ishidaira H, Hoshi S, Nagai K, Tamura Y, Takano M, Sakai T. Epidemiological study of the isolation of Aspergillus species from 2000 to 2011 at Nagaoka Red Cross Hospital. Igakukensa. 2014;63:486\u201391 (in Japanese with English abstract).","journal-title":"Igakukensa"},{"key":"299_CR25","first-page":"873","volume":"13","author":"B Barati","year":"2011","unstructured":"Barati B, Okhovvat SAR, Goljanian A, Omrani MR. Otomycosis in central Iran: a clinical and mycological study. Iran Red Crescent Med J. 2011;13:873\u20136.","journal-title":"Iran Red Crescent Med J"},{"key":"299_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/014556131209100308","volume":"91","author":"B Viswanatha","year":"2012","unstructured":"Viswanatha B, Sumatha D, Vijayashree MS. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review. Ear Nose Throat J. 2012;91:114\u201320.","journal-title":"Ear Nose Throat J"},{"key":"299_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0118997","volume":"10","author":"S Kathuria","year":"2015","unstructured":"Kathuria S, Shashta C, Singh PK, Agarwal P, Agarwal K, Hagen F, Meis JF, Chowdhary A. Molecular epidemiology and in vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. PLoS ONE. 2015;10:1\u201317.","journal-title":"PLoS ONE"},{"key":"299_CR28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","volume":"46","author":"MA Pfaller","year":"2002","unstructured":"Pfaller MA, Merrer SA, Hollis RJ, Jones RN. Sentry participants group antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program, 2000. Antimicrob Agents Chemother. 2002;46:1032\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"299_CR29","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1128\/AAC.49.12.5136-5138.2005","volume":"49","author":"M Cuenca-Estrella","year":"2005","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Garcia-Effron G, Monzon A, Rodriguez-Tudela JL. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi. Antimicrob Agents Chemother. 2005;49:5136\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"299_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3314\/jjmm.33.321","volume":"33","author":"T Hiratani","year":"1992","unstructured":"Hiratani T, Uchida K, Yamaguchi H, Oka H, Niwano Y, Ohmi T, Uchida M. In vitro antifungal activity of NND-318, a new antimycotic. Jpn J Med Mycol. 1992;33:321\u20138 (in Japanese with English abstract).","journal-title":"Jpn J Med Mycol."},{"key":"299_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10156-004-0327-1","volume":"10","author":"K Uchida","year":"2004","unstructured":"Uchida K, Nichiyama Y, Yamaguchi H. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent. J Infect Chemother. 2004;10:216\u20139.","journal-title":"J Infect Chemother"},{"key":"299_CR32","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1128\/AAC.01193-16","volume":"60","author":"M Abastabar","year":"2016","unstructured":"Abastabar M, Rahimi N, Meis JF, Aslani N, Khodavaisy S, Nabili M, Rezaei-Matehkolaei A, Makimura K, Badali H. Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and susceptible Aspergillus fumigatus strains. Antimicrob Agents Chemother. 2016;60:6916\u20139.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-018-0299-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0299-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0299-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T01:36:55Z","timestamp":1720661815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-018-0299-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1007\/s11046-018-0299-9","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors alone are responsible for the content of the paper and declare that they have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}